[微笑]
Pulmatrix Announces $40 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
LEXINGTON, Mass., Feb. 11, 2021 /PRNewswire/ -- Pulmatrix, Inc. (NASDAQ: PULM), a clinical stage bio
免责声明:上述内容仅代表发帖人个人观点,不构成本平台的任何投资建议。
1
举报
登录后可参与评论
暂无评论